| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 服务收入(元) | 2,218,844.63 | 5,653,524.80 | 2,480,700.43 |
| 销售商品收入(元) | 375,624.06 | 731,429.08 | 1,133,755.78 |
| 药品收入(元) | 1,893,022.64 | 7,778,546.45 | 3,119,650.91 |
| 医疗收入(元) | 57,191,712.51 | 99,736,964.67 | 38,866,031.62 |
| 营业成本(元) | |||
| 服务收入(元) | 530,063.30 | 1,086,146.91 | 558,790.83 |
| 销售商品收入(元) | 1,260,808.58 | 1,247,630.30 | 716,272.73 |
| 药品收入(元) | 4,944,806.68 | 8,089,723.67 | 3,312,605.81 |
| 医疗收入(元) | 43,847,566.64 | 79,081,929.39 | 35,150,616.56 |
| 毛利(元) | |||
| 服务收入(元) | 1,688,781.33 | 4,567,377.89 | 1,921,909.60 |
| 销售商品收入(元) | -885,184.52 | -516,201.22 | 417,483.05 |
| 药品收入(元) | -3,051,784.04 | -311,177.22 | -192,954.90 |
| 医疗收入(元) | 13,344,145.87 | 20,655,035.28 | 3,715,415.06 |
| 毛利率(%) | |||
| 服务收入(%) | 76.11 | 80.79 | 77.47 |
| 销售商品收入(%) | -235.66 | -70.57 | 36.82 |
| 药品收入(%) | -161.21 | -4.00 | -6.19 |
| 医疗收入(%) | 23.33 | 20.71 | 9.56 |
| 收入构成(%) | |||
| 服务收入(%) | 3.60 | 4.96 | 5.44 |
| 销售商品收入(%) | 0.61 | 0.64 | 2.49 |
| 药品收入(%) | 3.07 | 6.83 | 6.84 |
| 医疗收入(%) | 92.72 | 87.57 | 85.23 |
| 毛利构成(%) | |||
| 服务收入(%) | 15.22 | 18.72 | 32.79 |
| 销售商品收入(%) | -7.98 | -2.12 | 7.12 |
| 药品收入(%) | -27.50 | -1.28 | -3.29 |
| 医疗收入(%) | 120.26 | 84.67 | 63.38 |